Teriflunomide in relapsing MS: Outcomes by age, pre-treatment status on: June 01, 2021, 09:24:59 pm #1 Several of the authors here are affiliated with Sanofi-Aventis.From Therapeutic Advances in Neurological Disorders (May 18, 2021), "Teriflunnomide in relapsing multiple sclerosis: Outcomes by age and pre-treatment status":https://journals.sagepub.com/doi/full/10.1177/17562864211005588 Last Edit: September 15, 2024, 02:44:51 pm by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
